Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Theravance Biopharma R&D IP, LLC”

252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 8 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “Theravance Biopharma R&D IP, LLC” · 30,257 patents in full index Clear search

  1. US 9555041

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  2. US 9533962

    (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted
  3. US 9499487

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  4. US 9487514

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  5. US 9452161

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  6. US 9433598

    (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

    Theravance Biopharma R&D IP, LLC · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  7. US 9428457

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  8. US 9428489

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  9. US 9422245

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  10. US 9415041

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  11. US 9402840

    Crystalline form of a quinolinone-carboxamide compound

    Theravance Biopharma R&D IP, LLC · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  12. US 9388145

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted
  13. US 9365549

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  14. US 9353106

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted
  15. US 9334245

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted May 10, 2016 · Expires May 5, 2036

    granted
  16. US 9290491

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted
  17. US 9283183

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  18. US 9273008

    Dual-acting imidazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  19. US 9271965

    Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  20. US 9260414

    Inhibitors of hepatitic C virus

    Theravance Biopharma R&D IP, LLC · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  21. US 9249105

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance Biopharma R&D IP, LLC · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  22. US 9249099

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  23. US 9227933

    3-phenoxymethylpyrrolidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  24. US 9226896

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted